ICMR inks agreements with industry, academic partners to advance first-in-human phase-1 clinical trials

ICMR inks agreements with industry, academic partners to advance first-in-human phase-1 clinical trials

These include research studies over a small molecule for multiple myeloma, the development of a Zika vaccine, seasonal influenza vaccine trials and cell therapy studies for chronic lymphocytic leukemia These include research studies over a small molecule for multiple myeloma, the development of a Zika vaccine, seasonal influenza vaccine trials and cell therapy studies for chronic lymphocytic leukemia Health Health News, Wellbeing Tips, Diseases, Treatment and Nutrition | The Hindu

Leave a Reply

Your email address will not be published. Required fields are marked *